Table 3.
Cell type | Nanotopography | Advantages | Ref. |
Chondrocytes | (a) PCL nanofibrous scaffold (200-800 nm) in the presence of TGF-β1; (b) Collagen nanofibers of diameter 110 nm-1.8 μm | The differentiation of the stem cells into chondrocytes in the nanofibrous scaffold was comparable to an established cell pellet culture. Nanotopography supports chondrocyte growth and infiltration | [82,90] |
Osteoblasts | (a) Ceramics like HA, alumina and titania having nanostructures of grain sizes less than 100 nm and nanophase zinc oxide (23 nm); (b) PLGA, PLLA and PCL nanofibers (diameter 200-800 nm); (c) Nanotubes of diameter less than 100 nm | Enhanced proliferation and differentiation of MSC to osteoblasts | [67,77-79,105-113] |
Smooth muscle cells (SMC) | (a) PLGA and PCL, PLLA-CL nanofibers (diameter 200-800 nm); (b) Nanogratings of 350 nm in width, spacing, and depth imprinted on PMMA or PDMS | SMC adhesion was enhanced on the nanostructured substrates compared to the conventional submicron substrates | [114-118] |
Fibroblasts | (a) PLGA (85:15 ratio) nanofibers of diameter 500-800 nm; (b) Nanocolumns | Increased endocytic activity. Nanotopography can be used to improve hemocompatibility of blood-contacting biomaterials | [82] |
Nerve cells | (a) Silicon wafer in the range of 20-70 nm; (b) PLLA or PCL scaffolds via electrospinning and phase separation | The cell adhesion and viability significantly improved on the nanofeatured surface | [70,91] |
PCL: Polycaprolactone; TGF-β: Transforming growth factor-β; HA: Hydroxyapatite; PLGA: Poly-lactide-co-glycolide; PLLA: Poly-L-lactide acid; MSC: Mesenchymal stem cell; PMMA: Poly-methylmethacrylate; PDMS: Polydimethylsiloxane.